Literature DB >> 8567925

Cutaneous phaeohyphomycosis caused by Alternaria longipes in an immunosuppressed patient.

J Gené1, A Azón-Masoliver, J Guarro, F Ballester, I Pujol, M Llovera, C Ferrer.   

Abstract

Alternaria longipes was reported as the agent of a cutaneous infection in a patient with a neoplastic disease. The fungus has not been reported previously as causing disease in humans. It was distinguished by its rather small conidia with smooth or slightly verruculose walls and a pale brown beak which rarely extended into a secondary conidiophore. In vitro inhibitory activities of amphotericin B, ketoconazole, itraconazole, and miconazole were shown.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8567925      PMCID: PMC228575          DOI: 10.1128/jcm.33.10.2774-2776.1995

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  6 in total

1.  Cutaneous alternariosis in a liver transplant recipient.

Authors:  T Repiso; N Martin; P Huguet; J Luelmo; M Roca; U González-Castro; C Margarit; A Castells
Journal:  Clin Infect Dis       Date:  1993-05       Impact factor: 9.079

2.  Ungual and cutaneous phaeohyphomycosis caused by Alternaria alternata and Alternaria chlamydospora.

Authors:  S M Singh; J Naidu; M Pouranik
Journal:  J Med Vet Mycol       Date:  1990

3.  Cutaneous phaeohyphomycosis due to Alternaria alternata responding to itraconazole.

Authors:  M B Duffill; K E Coley
Journal:  Clin Exp Dermatol       Date:  1993-03       Impact factor: 3.470

4.  Phaeohyphomycosis in a cat caused by Alternaria infectoria E. G. Simmons.

Authors:  P J Roosje; G S de Hoog; J P Koeman; T Willemse
Journal:  Mycoses       Date:  1993 Nov-Dec       Impact factor: 4.377

5.  Subcutaneous alternariosis.

Authors:  A J Mitchell; A R Solomon; E S Beneke; T F Anderson
Journal:  J Am Acad Dermatol       Date:  1983-05       Impact factor: 11.527

6.  Comparative study of broth macrodilution and microdilution techniques for in vitro antifungal susceptibility testing of yeasts by using the National Committee for Clinical Laboratory Standards' proposed standard.

Authors:  F Barchiesi; A L Colombo; D A McGough; M G Rinaldi
Journal:  J Clin Microbiol       Date:  1994-10       Impact factor: 5.948

  6 in total
  4 in total

Review 1.  Melanized fungi in human disease.

Authors:  Sanjay G Revankar; Deanna A Sutton
Journal:  Clin Microbiol Rev       Date:  2010-10       Impact factor: 26.132

2.  Posaconazole therapy of disseminated phaeohyphomycosis in a murine model.

Authors:  John R Graybill; Laura K Najvar; Elizabeth Johnson; Rosie Bocanegra; David Loebenberg
Journal:  Antimicrob Agents Chemother       Date:  2004-06       Impact factor: 5.191

3.  Occurrence of itraconazole-tolerant micromycetes in the soil and food products.

Authors:  E Piecková; Z Jesenská
Journal:  Folia Microbiol (Praha)       Date:  1999       Impact factor: 2.629

4.  A rare case of phaeohyphomycosis caused by Fonsecaea pedrosoi in a child with nephrotic syndrome.

Authors:  C Nayyar; N Gulati; B L Sherwal
Journal:  Indian J Nephrol       Date:  2016 May-Jun
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.